Earnings Scheduled For November 7, 2022
Companies Reporting Before The Bell
• NAPCO Security Techs (NASDAQ:NSSC) is expected to report quarterly earnings at $0.13 per share on revenue of $36.34 million.
Oppenheimer Initiates Coverage On Revolution Medicines with Outperform Rating, Announces Price Target of $30
Oppenheimer analyst Jay Olson initiates coverage on Revolution Medicines (NASDAQ:RVMD) with a Outperform rating and announces Price Target of $30.
HC Wainwright & Co. Maintains Buy on Revolution Medicines, Lowers Price Target to $37
HC Wainwright & Co. analyst Robert Burns maintains Revolution Medicines (NASDAQ:RVMD) with a Buy and lowers the price target from $40 to $37.
LegalZoom.com, Toast And Some Other Big Stocks Moving Higher On Friday
Altimmune, Inc. (NASDAQ: ALT) jumped 28% to $17.64. B. Riley Securities maintained Altimmune with a Buy and raised the price target from $21 to $26.
Revolution Medicines Q2 EPS $(0.82) Beats $(0.84) Estimate, Sales $9.12M Beat $7.02M Estimate
Revolution Medicines (NASDAQ:RVMD) reported quarterly losses of $(0.82) per share which beat the analyst consensus estimate of $(0.84) by 2.38 percent. This is a 36.67 percent decrease over losses of $(0.60) per share
Earnings Scheduled For August 9, 2022
Companies Reporting Before The Bell
• Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter.
$10 Million Bet On This Financial Services Stock? 3 Stocks Insiders Are Buying
Although US stocks closed mixed on Monday, there were a few notable insider trades.
12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers
Talis Biomedical (NASDAQ:TLIS) shares moved upwards by 10.6% to $0.94 during Tuesday's after-market session. The company's market cap stands at $25.0 million.